Susan Silverberg

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Google:
"Susan Silverberg"
Mean distance: 19.15 (cluster 25)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wright CB, Shah NH, Mendez AJ, et al. (2016) Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study. Stroke; a Journal of Cerebral Circulation
Walker MD, Nishiyama KK, Zhou B, et al. (2016) Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture and Stiffness in Primary Hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. jc20154218
McMahon DJ, Carrelli A, Palmeri N, et al. (2015) Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis. The Journal of Clinical Endocrinology and Metabolism. jc20153202
Cong E, Walker MD, Kepley A, et al. (2015) Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. JC20152105
Shah NH, Dong C, Elkind MS, et al. (2015) Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study. Arteriosclerosis, Thrombosis, and Vascular Biology
Walker MD, Cong E, Lee JA, et al. (2015) Low vitamin D levels have become less common in primary hyperparathyroidism. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa
Walker MD, Cong E, Lee JA, et al. (2015) Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical and Densitometric Presentation. The Journal of Clinical Endocrinology and Metabolism. jc20152022
Rubin MR, Goldfine AB, McMahon DJ, et al. (2015) Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitus. Endocrine
Silverberg SJ, Clarke BL, Peacock M, et al. (2014) Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. The Journal of Clinical Endocrinology and Metabolism. 99: 3580-94
Bilezikian JP, Brandi ML, Eastell R, et al. (2014) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. The Journal of Clinical Endocrinology and Metabolism. 99: 3561-9
See more...